Organogenesis Provides Update on Second Phase 3 ReNu Study
Company maintains confidence in ReNu as innovative pain management therapy Second Phase…
Teva to Host Conference Call to Discuss Third Quarter 2025 Financial Results at 8 a.m. ET on November 5, 2025
September 25, 2025 16:30 ET | Source: Teva Pharmaceutical Industries Ltd TEL…
2025 first-half earnings: RIBER confirms the rollout of its roadmap and its annual outlook.
2025 first-half earnings: RIBER confirms the rollout of its roadmap and its…
Quadients Accredited Platform Already Set to Process More Than 215Million Electronic Invoices Annually by September 2026
With over 10% of the French market already secured through leading enterprises…
TomTom launches innovative road alert assistant and app for enhanced driver experience
AMSTERDAM, Sept. 25, 2025 (GLOBE NEWSWIRE) -- TomTom (TOM2), the location technology…
Sapu Nanos Sapu003 Advances to Human Clinical Testing – Transforming Everolimus Delivery with Full Bioavailability for Breast Cancer Patients
Sapu003 Designed to Overcome Limitations of Afinitor®, FDA-Approved Oral Everolimus, Delivering Full…
Range Impact Announces $550,000 Capital Raise
Cleveland, Ohio, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTCQB:…
Verano to Report Third Quarter 2025 Financial Results on October 29, 2025
CHICAGO, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (Cboe CA:…
Himax WiseEye Ultralow Power AI Sensing Technology Adopted in Acers New Ultra-Thin and Lightweight AI PC
Enabling Smart Human Detection and Interactive Awareness to Elevate AI in Endpoint…
Lantheus and GE HealthCare Announce Exclusive Licensing Agreement for Prostate Cancer Imaging Agent PYLARIFY (Piflufolastat F 18) in Japan
BEDFORD, Mass. and CHICAGO and TOKYO, Sept. 24, 2025 (GLOBE NEWSWIRE) --…
